Cosmos Health Inc.

Cosmos Health Inc.

COSM · NASDAQ · Healthcare / Medical Distribution

3.24USD+3.03 (+1460.69%)

Price History

Full chart

Market Stats

Previous Close0.2076
Open4.29
Day Range3.00 – 4.35
52-Week Range0.1616 – 1.32
Volume352.12K
Market Cap35.38M
P/E (TTM)0.00
Forward P/E5.84
EPS-0.67
Dividend Yield0.00%
Beta4.17
50-Day Avg0.2412
200-Day Avg0.3329

About

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus. The company provides prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It offers ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names; and other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag; Otikon ear drops, which is a Class II medical device in the form of ear drops; and baby foods, such as organic powder milk, pasta with minced meat, whole grain rice cereals, whole grain cereal porridges, and organic rice creams with vanilla milk, as well as pear, carrot and banana purée under the Bio-bebe brand. It serves wholesalers and retail healthcare providers. The company was founded in 2009 and is headquartered in Thessaloniki, Greece.

Company Details

  • SectorHealthcare
  • IndustryMedical Distribution
  • CEOMr. Grigorios Siokas
  • Employees163
  • Headquarters5 Agiou Georgiou Str, Pilea, Thessaloniki, Greece, 55438, USA
  • Websitehttps://www.cosmoshealthinc.com

Leadership

  • Mr. Grigorios SiokasChairman & CEO · b. 1965
  • Mr. Georgios TerzisChief Financial Officer · b. 1983
  • Mr. Nikolaos BardakisChief Operating Officer · b. 1969
  • Mr. Demetrios G. DemetriadesSecretary & Independent Director · b. 1965
  • Prof. Dimitrios TrafalisHead of Oncology

Financials

Income Statement

Currency: USD2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue----902.37K7.64M533.80K6.76M30.01M37.08M39.68M55.41M56.24M50.35M53.38M54.43M65.27M
Growth (%)-----+746.55%-93.01%+1165.53%+344.28%+23.56%+6.99%+39.65%+1.50%-10.48%+6.02%+1.97%+19.93%
Cost of Revenue----557.00K70.81K484.81K6.15M28.06M34.68M36.01M47.35M47.91M44.39M49.03M50.12M57.38M
Gross Profit----902.37K7.57M48.99K601.04K1.96M2.41M3.66M8.06M8.33M5.96M4.35M4.31M7.90M
Gross Margin----100.00%99.07%9.18%8.90%6.52%6.50%9.23%14.55%14.81%11.83%8.15%7.92%12.10%
Operating Expense----613.66K452.44K491.45K803.55K6.83M3.64M3.92M5.35M12.86M13.43M26.18M19.86M24.44M
Operating Income-4.60K-3.79M-169.25K-455288.71K7.12M-442.46K-202.51K-4.87M-1.23M-255.81K2.71M-4.53M-7.47M-21.83M-15.54M-16.54M
Operating Margin----31.99%93.15%-82.89%-3.00%-16.23%-3.31%-0.64%4.90%-8.06%-14.84%-40.90%-28.56%-25.34%
EBITDA-4.60K-3.79M-168.41K-455288.71K7.13M-6.59M-384.77K-4.54M-2.19M-988.59K4.39M-4.13M-8.90M--13.92M-15.15M
EBITDA Margin----31.99%93.28%-1234.90%-5.70%-15.14%-5.91%-2.49%7.93%-7.34%-17.68%--25.58%-23.22%
Net Income-4.60K-3.79M-169.25K-455246.59K6.04M-6.69M-601.00K-6.21M-9.06M-3.30M820.79K-7.96M-13.83M-18.54M-16.18M-19.14M
Net Income Margin----27.33%79.13%-1252.88%-8.90%-20.69%-24.43%-8.31%1.48%-14.16%-27.47%-34.74%-29.73%-29.33%
R&D------0000----164.86K533.29K519.36K
R&D as % of Total Revenue------0.00%0.00%0.00%0.00%----0.31%0.98%0.80%
Interest Expense4.60K9528353.73K2.44K74.34K90.38K206.01K1.64M6.81M1.73M2.80M3.58M3.97M866.48K1.01M2.62M
Interest Expense % of Total Revenue----0.27%0.97%16.93%3.05%5.46%18.36%4.37%5.04%6.37%7.88%1.62%1.86%4.02%

Balance Sheet

Currency: USD2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-47015.24K40867.05K7.23M657.62K3.12M10.68M20.69M23.88M43.84M49.43M68.04M66.01M54.31M65.48M
Total Liabilities4.60K17.95K20.00K1.40K920.73K1.76M1.91M4.87M13.70M24.01M30.34M48.01M45.05M28.38M29.97M29.78M47.05M
Total Equity-4.60K-17.48K-4.76K-1.40K-53.68K5.47M-1.25M-1.75M-3.03M-3.32M-6.46M-4.16M4.38M39.66M36.04M24.53M18.42M
Cash-47015.24K40864.49K446.60K198.05K716.59K782.85K864.34K38.54K628.39K286.49K20.75M3.83M315.11K715.67K
Total Debt-15.87K--165.00K504.12K474.14K3.20M10.18M16.58M19.29M32.04M27.12M12.03M-11.82M19.97M
Net Debt-15.40K-15.24K-40-699.49K57.51K276.09K2.48M9.40M15.71M19.25M31.41M26.84M-8.72M7.43M11.51M19.25M

Cash Flow

Currency: USD2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow--69.60K-87.29K31831.40K6.53M-497.09K-2.13M-8.76M-1.56M-4.79M-11.50M-7.10M-14.87M-15.64M-7.72M-8.45M
Investing Cash Flow----18.15K-6.76M-43.95K-144.72K-14.48K-195.77K588.93K-117.74K-826.82K-826.82K--798.27K-2.01M
Financing Cash Flow-70.07K102.06K9172.37K504.12K329.12K2.74M9.29M1.99M3.59M12.46M7.27M35.05M12.69M5.05M14.06M
Capital Expenditure000021.47K21.47K43.95K12.82K55.34K503.36K672.79K117.74K890.52K383.07K9.17M418.07K55.67K
Free Cash Flow--69.60K-87.29K31831.40K6.50M-541.04K-2.14M-8.82M-2.06M-5.46M-11.62M-7.99M-15.25M-24.80M-8.14M-8.50M
Dividends Paid------0000--7.63M32.00M-6.20M-
FCF to OCF-100.00%100.00%100.00%100.00%99.67%108.84%100.60%100.63%132.36%114.05%101.02%112.55%102.58%158.63%105.42%100.66%
Dividend Paid to FCF------0.00%0.00%0.00%0.00%---95.56%-209.82%--76.15%-

Earnings

Report DateJul 31, 2010Oct 31, 2010Jan 31, 2011Apr 30, 2011Jul 31, 2011Oct 31, 2011Jan 31, 2012Apr 30, 2012Jul 31, 2012Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016May 22, 2017Aug 11, 2017Nov 20, 2017Dec 31, 2017Apr 17, 2018Aug 14, 2018Nov 13, 2018Dec 31, 2018Apr 16, 2019Aug 19, 2019Nov 14, 2019Dec 31, 2019Apr 14, 2020Aug 13, 2020Nov 16, 2020Dec 31, 2020Apr 15, 2021Aug 16, 2021Nov 15, 2021Dec 31, 2021Apr 15, 2022Aug 19, 2022Nov 14, 2022Dec 31, 2022May 16, 2023Aug 15, 2023Nov 20, 2023Dec 31, 2023Apr 12, 2024Aug 19, 2024Nov 14, 2024May 15, 2025Aug 18, 2025Nov 14, 2025Dec 31, 2025Apr 15, 2026Aug 19, 2026Nov 13, 2026
EPS Estimate---------------------------------------------------0.20-0.14-0.14-0.11-0.080.01-0.01-0.04-0.040.01-0.05
EPS Actual-44.47-0.09-0.12-0.90-0.63-1.63-0.57-0.55-0.61-0.202.501.221.849.44-0.49-0.22-0.26-0.20-12.63-0.14-0.23-0.19-0.64-0.16-0.22-0.02-6.19-0.260.060.24-18.75-0.75-0.12-0.120.180.010.100.06-1.59-0.06-0.15-0.11-13.27-0.52-0.93-0.08-3.82-7.51-0.09-0.27-1.70-0.11-0.15-0.450.01-0.06-0.17-0.36-0.36-0.03-
Surprise---------------------------------------------------749.10%21.43%-7.14%-309.09%112.50%-700.00%-1600.00%-809.75%-800.00%-400.00%-
Timing-----------------------------------------------After-hoursPre-marketAfter-hours--After-hoursAfter-hours-After-hoursAfter-hours-After-hours--

Key Statistics & Ratios

Market Cap35.38M
Enterprise Value55.30M
Trailing P/E0.00
Forward P/E5.84
PEG Ratio0.00
Price / Sales0.48
Price / Book1.99
EPS-0.67
Book Value0.256
Revenue (TTM)73.73M
Gross Profit (TTM)7.57M
EBITDA-16.79M
Profit Margin-33.08%
Operating Margin-15.41%
Return on Equity-104.00%
Return on Assets-18.42%
Shares Outstanding100.63M
Shares Float78.78M
Beta4.17
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 1 analystsTarget 4.50
  • Buy
    1

Ownership Breakdown

Institutions
3.67%
Insiders
21.68%
Retail / Other
74.65%

Top Institutional Holders

  • Renaissance Technologies Corp
    390.50K0.39%
  • Geode Capital Management, LLC
    318.11K0.32%
  • BlackRock Inc
    267.80K0.27%
  • Vanguard Capital Management, LLC
    140.01K0.14%
  • Vanguard Fiduciary Trust Co
    95.73K0.10%
  • HRT FINANCIAL LLC
    67.28K0.07%
  • State Street Corp
    45.24K0.04%
  • XTX Topco Ltd
    40.48K0.04%
  • Northern Trust Corp
    20.55K0.02%
  • Susquehanna International Group, LLP
    17.73K0.02%
  • KESTRA PRIVATE WEALTH SERVICES, LLC
    13.00K0.01%
  • UBS Group AG
    12.73K0.01%
  • NATIONAL BANK OF CANADA /FI/
    6.36K0.01%
  • SIMPLEX TRADING, LLC
    3.80K0.00%
  • Group One Trading, LLC
    2.37K0.00%
  • Hanson Mcclain Inc
    1.24K0.00%
  • Citigroup Inc
    9900.00%

Top Fund Holders

  • Fidelity Extended Market Index
    216.33K0.21%
  • Fidelity Series Total Market Index
    28.54K0.03%
  • Fidelity Total Market Index
    21.66K0.02%

Stock Splits

  • Nov 13, 20261:20
  • Nov 21, 20171:10